Intervacc is trading 19.11% down now at €0.06 after sector-wide biotech weakness and risk reduction ahead of Federal Reserve Chair Kevin Warsh’s Jackson Hole speech.
- No fresh company-specific announcement for August 31, 2026 was identified.
- The latest major company disclosure was the January–June 2026 interim report, published August 20.
- Upcoming results are scheduled for November 12.